Goldman Sachs’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-418,302
Closed -$72M 5848
2021
Q3
$72M Buy
418,302
+300,878
+256% +$51.8M 0.02% 836
2021
Q2
$14.7M Sell
117,424
-239,613
-67% -$30.1M ﹤0.01% 1961
2021
Q1
$48.4M Buy
357,037
+39,710
+13% +$5.39M 0.01% 1050
2020
Q4
$40.6M Sell
317,327
-163,415
-34% -$20.9M 0.01% 1098
2020
Q3
$54.1M Sell
480,742
-12,269
-2% -$1.38M 0.02% 809
2020
Q2
$47M Buy
493,011
+59,141
+14% +$5.63M 0.01% 900
2020
Q1
$39M Buy
433,870
+113,865
+36% +$10.2M 0.01% 938
2019
Q4
$17M Sell
320,005
-76,537
-19% -$4.06M ﹤0.01% 1725
2019
Q3
$15.7M Sell
396,542
-33,867
-8% -$1.34M ﹤0.01% 1678
2019
Q2
$17.7M Sell
430,409
-30,532
-7% -$1.25M 0.01% 1655
2019
Q1
$21.5M Buy
460,941
+203,799
+79% +$9.49M 0.01% 1562
2018
Q4
$11.2M Sell
257,142
-202,869
-44% -$8.84M ﹤0.01% 1875
2018
Q3
$26.3M Sell
460,011
-80,869
-15% -$4.63M 0.01% 1486
2018
Q2
$26.2M Sell
540,880
-14,139
-3% -$686K 0.01% 1471
2018
Q1
$21.7M Sell
555,019
-54,962
-9% -$2.15M 0.01% 1529
2017
Q4
$25.9M Sell
609,981
-22,700
-4% -$963K 0.01% 1423
2017
Q3
$23.6M Buy
632,681
+112,624
+22% +$4.2M 0.01% 1485
2017
Q2
$15.8M Buy
520,057
+16,618
+3% +$505K ﹤0.01% 1683
2017
Q1
$13.3M Buy
503,439
+29,634
+6% +$784K ﹤0.01% 1714
2016
Q4
$12.1M Sell
473,805
-361,578
-43% -$9.23M ﹤0.01% 1721
2016
Q3
$30.2M Buy
835,383
+418,509
+100% +$15.1M 0.01% 1258
2016
Q2
$14.2M Buy
416,874
+199,547
+92% +$6.78M ﹤0.01% 1582
2016
Q1
$5.74M Buy
217,327
+200,946
+1,227% +$5.3M ﹤0.01% 2001
2015
Q4
$799K Buy
16,381
+6,545
+67% +$319K ﹤0.01% 3007
2015
Q3
$245K Sell
9,836
-18,804
-66% -$468K ﹤0.01% 3727
2015
Q2
$906K Buy
28,640
+17,388
+155% +$550K ﹤0.01% 3002
2015
Q1
$428K Sell
11,252
-5,147
-31% -$196K ﹤0.01% 3416
2014
Q4
$639K Buy
+16,399
New +$639K ﹤0.01% 3219